化合物简介
Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
基本信息
中文名称
妥曲珠利砜
英文名称
1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione
中文别名
托曲珠利砜、1-甲基-3-{3-甲基-4-[4-(三氟甲基磺酰)苯氧基]苯基}-1,3,5-三嗪-2,4,6(1H,3H,5H)-三酮
英文别名
Toltrazuril sulfone、1-methyl-3-[3-methyl-4-(4-trifluoromethanesulfonyl-phenoxy)-phenyl]-[1,3,5]triazinane-2,4,6-trione、Ponazuril、Marquis、toltrazuril、Ponazuril [INN]、1-Methyl-3-{3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl}-1,3,5-triazine-2,4,6(1H,3H,5H)-trione、UNII-JPW84AS66U
CAS号
69004-04-2
分子式
C18H14F3N3O6S
分子量
457.38
精确质量
457.056
PSA
128.61
LOGP
2.6995
编号系统
MDL号
MFCD09263475
物化性质
密度
1.507g/cm3
折射率
1.572
